Topics

Videos

Albert Thigpen, co-founder, Talentwise Consulting, explains how to use these tactics in order to anticipate the future US healthcare policy environment.

Access Insights 2024: Reassessing Pricing and Commercialization Approaches

Albert Thigpen, co-founder, Talentwise Consulting, offers highlights of the drug commercialization panel that he participated in.

Access Insights 2024: Key Nuggets Surrounding the Chess Endgame

Articles

How emerging biotech companies can create fruitful partnerships between home office commercial teams and the field force to enable this intelligence gathering, while driving commercial success.

Operating Without a Commercial Blueprint: Empowering the Field for Niche Therapy Launches

The offering will become available in 49 states by next year. 

Walmart Introduces Same-Day Prescription Delivery Service

A panel dives into the current and future outlook of healthcare policies. 

Access Insights 2024: Playing the Chess Endgame 

Session dives into how healthcare policy implementation impacts stakeholders long-term.  

Access Insights 2024: Practicing Proactivity by Mapping Out Future Chessboard Moves

The session dives into the obstacles surrounding data usability, mandate compliance, initial adoption, and limitations in this arena. 

Access Insights 2024: Analyzing Drug Pricing and Reimbursement Data Amid a New Wave of CMS Price Requirements 

The conference’s opening keynote sets the scene for 2025 and the years to come. 

Access Insights 2024: Commercialization’s Financial Headwinds and Tailwinds

The company’s annual edition reveals the latest numbers in the sector, including a rise in average employer-sponsored health insurance premiums for single and family coverage of 24% and 28% respectively. 

KFF Releases Results of Employer Health Benefits Survey

A deep dive into the future of patient service programs and the value of transparency throughout the process.

Business and Finance